Guidance Point Advisors’s Sanofi SNY Stock Holding History

Guidance Point Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-71	Closed	-$3K	–	359
2021 Q3	$3K	Buy	+71	New	+$3.61K	﹤0.01%	378

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Guidance Point Advisors's SNY Position: Q4 2021 in Review

Guidance Point Advisors sold out of Sanofi (SNY) in Q4 2021, closing a stake of 71 shares — an estimated $3K sold.

Guidance Point Advisors first reported a position in SNY in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

Guidance Point Advisors reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
Guidance Point Advisors sold 71 Sanofi shares in Q4 2021, an estimated $3K.
Guidance Point Advisors first reported a position in Sanofi in Q3 2021 and held it in 1 quarter.
Guidance Point Advisors's Sanofi position peaked at $3K in Q3 2021.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.